US health regulators are expected to authorize a booster shot of Pfizer and BioNTech's COVID-19 vaccine for children aged 5 to 11 as soon as Tuesday, Reuters reported on Monday, citing the New York Times.
People familiar with the matter said a meeting of outside vaccine experts on an advisory committee to the Centers for Disease Control and Prevention has been scheduled for Thursday.